TrimTech adds $14m in funding to accelerate neurodegenerative disease treatments

TrimTech Therapeutics announced an additional $14 million in seed funding, bringing the round to $47 million (£35 million). The extension was led by Johnson & Johnson Innovation, JJDC, Inc., and BGF, who join existing investors including Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures…

View Post on Scour ↗

More from longevity.technology on Scour.